Summit Therapeutics, Inc. (SMMT)
12.72
-0.44
(-3.31%)
USD |
NASDAQ |
Aug 24, 16:00
12.72
0.00 (0.00%)
After-Hours: 20:00
Summit Therapeutics Total Liabilities (Quarterly) : 122.20M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 122.20M |
| March 31, 2026 | 101.92M |
| December 31, 2025 | 92.32M |
| September 30, 2025 | 69.47M |
| June 30, 2025 | 64.60M |
| March 31, 2025 | 39.49M |
| December 31, 2024 | 46.81M |
| September 30, 2024 | 64.93M |
| June 30, 2024 | 146.78M |
| March 31, 2024 | 132.57M |
| December 31, 2023 | 125.26M |
| September 30, 2023 | 119.10M |
| June 30, 2023 | 117.77M |
| March 31, 2023 | 121.42M |
| December 31, 2022 | 537.51M |
| September 30, 2022 | 22.08M |
| June 30, 2022 | 44.40M |
| March 31, 2022 | 52.06M |
| December 31, 2021 | 30.09M |
| September 30, 2021 | 26.38M |
| June 30, 2021 | 26.09M |
| March 31, 2021 | 76.39M |
| December 31, 2020 | 23.04M |
| September 30, 2020 | 20.00M |
| Date | Value |
|---|---|
| June 30, 2020 | |
| March 31, 2020 | 21.40M |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | |
| January 31, 2019 | 22.66M |
| October 31, 2018 | 21.46M |
| July 31, 2018 | 18.00M |
| April 30, 2018 | 24.93M |
| January 31, 2018 | 81.26M |
| October 31, 2017 | 43.25M |
| July 31, 2017 | 49.65M |
| April 30, 2017 | 50.31M |
| January 31, 2017 | 51.68M |
| October 31, 2016 | 51.11M |
| July 31, 2016 | 5.392M |
| April 30, 2016 | 5.672M |
| January 31, 2016 | 5.593M |
| October 31, 2015 | 5.450M |
| July 31, 2015 | 5.284M |
| April 30, 2015 | 5.259M |
| January 31, 2015 | 6.653M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovelStem International Corp. | 2.097M |
| Brainstorm Cell Therapeutics, Inc. | 12.38M |
| Kezar Life Sciences, Inc. | 2.762M |
| Protara Therapeutics, Inc. | 14.78M |
| Clene, Inc. | 47.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 752.18M |
| Shareholders Equity (Quarterly) | 629.98M |
| Debt to Equity Ratio | 0.0324 |
| Current Ratio | 6.958 |
| Net Debt Paydown Yield | -0.02% |